These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27807757)

  • 1. Heart Failure Secondary to Chagas Disease: an Emerging Problem in Non-endemic Areas.
    Traina M; Meymandi S; Bradfield JS
    Curr Heart Fail Rep; 2016 Dec; 13(6):295-301. PubMed ID: 27807757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chagas disease as a cause of heart failure and ventricular arrhythmias in patients long removed from endemic areas: an emerging problem in Europe.
    Vannucchi V; Tomberli B; Zammarchi L; Fornaro A; Castelli G; Pieralli F; Berni A; Yacoub S; Bartoloni A; Olivotto I
    J Cardiovasc Med (Hagerstown); 2015 Dec; 16(12):817-23. PubMed ID: 25022923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chagas cardiomyopathy and heart failure: From epidemiology to treatment.
    Santos É; Menezes Falcão L
    Rev Port Cardiol (Engl Ed); 2020 May; 39(5):279-289. PubMed ID: 32532535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chagas heart disease: A contemporary review.
    Velasco A; Morillo CA
    J Nucl Cardiol; 2020 Apr; 27(2):445-451. PubMed ID: 30022404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developments in the management of Chagas cardiomyopathy.
    Tanowitz HB; Machado FS; Spray DC; Friedman JM; Weiss OS; Lora JN; Nagajyothi J; Moraes DN; Garg NJ; Nunes MC; Ribeiro AL
    Expert Rev Cardiovasc Ther; 2015 Dec; 13(12):1393-409. PubMed ID: 26496376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy.
    Muratore CA; Baranchuk A
    Vasc Health Risk Manag; 2010 Aug; 6():593-601. PubMed ID: 20730015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Arrhythmias and the indeterminate form of Chagas' disease].
    Pereira Barretto AC; Bellotti G; Sosa E; Grupi C; Mady C; Ianni BM; Fernández EA; Pileggi F
    Arq Bras Cardiol; 1986 Sep; 47(3):197-9. PubMed ID: 3109354
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chagas' disease and ischemic stroke].
    Carod-Artal FJ
    Neurologia; 2006 Apr; 21(3):135-49. PubMed ID: 16575627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy.
    Martí-Carvajal AJ; Kwong JS
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD009077. PubMed ID: 27388039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke history and Chagas disease are independent predictors of silent cerebral microembolism in patients with congestive heart failure.
    Jesus PA; Neville I; Cincurá C; Menezes DF; Vieira-de-Melo RM; Lacerda AM; Viana LC; Pereira DF; Ribeiro-dos-Santos V; Reis FJ; Macedo C; Oliveira-Filho J
    Cerebrovasc Dis; 2011; 31(1):19-23. PubMed ID: 20980749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin lesions, malaise, and heart failure in a renal transplant recipient.
    Kocher C; Segerer S; Schleich A; Caduff R; Wyler LG; Müller V; Beck B; Blum J; Kamarachev J; Mueller NJ
    Transpl Infect Dis; 2012 Aug; 14(4):391-7. PubMed ID: 22487319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke due to Chagas' cardiomyopathy or noncompaction.
    Finsterer J; Stöllberger C
    Arq Bras Cardiol; 2011 May; 96(5):427; author reply 428. PubMed ID: 21603799
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological interventions for treating heart failure in patients with chagas cardiomyopathy.
    Hidalgo R; Martí-Carvajal AJ; Kwong JS; Simancas-Racines D; Nicola S
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009077. PubMed ID: 23152267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Referring to noncompaction of the myocardium, Chagas' disease and dysfunction.
    Pereira R
    Arq Bras Cardiol; 2011 May; 96(5):429; author reply 429-30. PubMed ID: 21603800
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.
    Bestetti RB; Theodoropoulos TA; Cardinalli-Neto A; Cury PM
    Am Heart J; 2008 Sep; 156(3):422-30. PubMed ID: 18760121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chagas Cardiomyopathy in Latin America Review.
    Vieira JL; Távora FRF; Sobral MGV; Vasconcelos GG; Almeida GPL; Fernandes JR; da Escóssia Marinho LL; de Mendonça Trompieri DF; De Souza Neto JD; Mejia JAC
    Curr Cardiol Rep; 2019 Feb; 21(2):8. PubMed ID: 30747287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chagas disease and stroke.
    Carod-Artal FJ; Gascon J
    Lancet Neurol; 2010 May; 9(5):533-42. PubMed ID: 20398860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke in Chagas disease: from pathophysiology to clinical practice.
    Lage TAR; Tupinambás JT; Pádua LB; Ferreira MO; Ferreira AC; Teixeira AL; Nunes MCP
    Rev Soc Bras Med Trop; 2022; 55():e0575. PubMed ID: 35674560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncompaction of the myocardium, Chagas' disease and dysfunction: a case report.
    Mello RP; Szarf G; Nakano E; Dietrich C; Cirenza C; Paola AA
    Arq Bras Cardiol; 2010 Jul; 95(1):e4-6. PubMed ID: 20694397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chagas disease and transfusion medicine: a perspective from non-endemic countries.
    Angheben A; Boix L; Buonfrate D; Gobbi F; Bisoffi Z; Pupella S; Gandini G; Aprili G
    Blood Transfus; 2015 Oct; 13(4):540-50. PubMed ID: 26513769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.